Kazia Therapeutics Limited (KZIA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Kazia Therapeutics Limite...

    NASDAQ: KZIA · Real-Time Price · USD
    6.56
    0.25 (3.96%)
    At close: Oct 03, 2025, 3:59 PM
    6.36
    -3.05%
    Pre-market: Oct 06, 2025, 07:21 AM EDT

    Kazia Therapeutics Income Statement

    Financials in AUD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021 Dec 31, 2020
    Revenue
    		 11.14K 2.48M 5.00 555.00 n/a -2.9M 10K 15.18M 1.17K
    Cost of Revenue
    		 n/a n/a n/a n/a n/a n/a n/a 2.88M n/a
    Gross Profit
    		 11.14K 2.48M 5.00 555.00 n/a -2.9M 10K 12.3M 1.17K
    Operating Income
    		 -4.68M -9.79M -4.44M -10.51M -13.64M -11.94M -13.45M 55.65K -6.43M
    Interest Income
    		 n/a 5.55K 6.45K 22.42K 139.00 105.00 1.99K 11.42K 30.82K
    Pretax Income
    		 -5.29M -9.04M -4.48M -7.01M -13.72M -11.86M -13.52M -2.39M -6.51M
    Net Income
    		 -5.23M -17.95M -8.82M -6.88M -13.59M -11.81M -13.2M -2.06M -6.36M
    Selling & General & Admin
    		 2.55M 9.01M 4.56M 4.31M 4.28M 2.76M 2.48M 3.45M 3.58M
    Research & Development
    		 2.14M 13.05M 4.33M 6.2M 9.36M 9.18M 10.99M 11.68M 2.86M
    Other Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 4.7M 22.06M 8.88M 7.04M 13.72M 11.86M 13.53M 17.59M 6.54M
    Interest Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a 127.04K n/a n/a n/a
    Cost & Expenses
    		 4.7M 22.06M 8.88M 7.04M 13.72M 11.86M 13.53M 17.59M 6.54M
    Income Tax Expense
    		 67.77K 67.73K 67.77K 135.55K 135.55K 52.11K 315.97K 335.25K 149.1K
    Shares Outstanding (Basic)
    		 850.25K 575.2K 479.6K 456K 291.4K 266K 264K 264K 214.8K
    Shares Outstanding (Diluted)
    		 850.32K 575.2K 479.6K 456K 291.4K 266K 264K 264K 214.8K
    EPS (Basic)
    		 -6.15 -31.2 -18.4 -15.1 -46.65 -44.4 -50 -7.8 -29.6
    EPS (Diluted)
    		 -6.15 -31.2 -18.4 -15.1 -46.65 -44.4 -50 -7.8 -29.6
    EBITDA
    		 -4.22M -18.64M -7.95M -9.58M -12.7M -11M -12.51M 778.79K -5.89M
    EBIT
    		 -4.68M -19.58M -8.88M -10.51M -13.64M -11.94M -13.45M 55.65K -6.43M
    Depreciation & Amortization
    		 467.36K 934.29K 934.71K 934.72K 934.74K 934.71K 934.71K 723.14K 542.17K

    Add to Watchlist